GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Cyclically Adjusted PB Ratio

Active Biotech AB (OSTO:ACTI) Cyclically Adjusted PB Ratio : 0.69 (As of Jun. 02, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Cyclically Adjusted PB Ratio?

As of today (2024-06-02), Active Biotech AB's current share price is kr0.56. Active Biotech AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr0.81. Active Biotech AB's Cyclically Adjusted PB Ratio for today is 0.69.

The historical rank and industry rank for Active Biotech AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:ACTI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.31   Med: 0.8   Max: 2.17
Current: 0.69

During the past years, Active Biotech AB's highest Cyclically Adjusted PB Ratio was 2.17. The lowest was 0.31. And the median was 0.80.

OSTO:ACTI's Cyclically Adjusted PB Ratio is ranked better than
72.94% of 654 companies
in the Biotechnology industry
Industry Median: 1.745 vs OSTO:ACTI: 0.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Active Biotech AB's adjusted book value per share data for the three months ended in Mar. 2024 was kr0.056. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.81 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Active Biotech AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Active Biotech AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Cyclically Adjusted PB Ratio Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.93 0.78 0.70 0.51

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.65 0.69 0.51 0.72

Competitive Comparison of Active Biotech AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Active Biotech AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Cyclically Adjusted PB Ratio falls into.



Active Biotech AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Active Biotech AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.56/0.81
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Active Biotech AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.056/132.2054*132.2054
=0.056

Current CPI (Mar. 2024) = 132.2054.

Active Biotech AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.965 100.432 2.587
201409 1.597 100.161 2.108
201412 2.895 100.225 3.819
201503 2.079 99.950 2.750
201506 1.666 99.995 2.203
201509 1.538 100.228 2.029
201512 1.075 100.276 1.417
201603 0.986 100.751 1.294
201606 0.906 101.019 1.186
201609 0.844 101.138 1.103
201612 1.026 102.022 1.330
201703 0.948 102.022 1.228
201706 0.822 102.752 1.058
201709 0.775 103.279 0.992
201712 0.437 103.793 0.557
201803 0.377 103.962 0.479
201806 0.526 104.875 0.663
201809 0.483 105.679 0.604
201812 0.438 105.912 0.547
201903 0.398 105.886 0.497
201906 0.370 106.742 0.458
201909 0.324 107.214 0.400
201912 0.268 107.766 0.329
202003 0.218 106.563 0.270
202006 0.169 107.498 0.208
202009 0.129 107.635 0.158
202012 0.131 108.296 0.160
202103 0.342 108.360 0.417
202106 0.292 108.928 0.354
202109 0.249 110.338 0.298
202112 0.185 112.486 0.217
202203 0.123 114.825 0.142
202206 0.067 118.384 0.075
202209 0.167 122.296 0.181
202212 0.117 126.365 0.122
202303 0.078 127.042 0.081
202306 0.040 129.407 0.041
202309 0.004 130.224 0.004
202312 0.085 131.912 0.085
202403 0.056 132.205 0.056

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Active Biotech AB  (OSTO:ACTI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Active Biotech AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Active Biotech AB (OSTO:ACTI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines